NaomiHaasMD

PubMed

• 2 citations
  Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
  Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Stefan Symeonides, Jaroslav Hajek, Thomas Ferguson, Yen-Hwa Chang, Jae Lyun Lee, Naomi Haas, Piotr Sawr...> ;The Oncologist. 2024 Feb 2
• Nivolumab Plus Ipilimumab with Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma.
  Michael C Soulen, Naomi B Haas> ;Journal of Vascular and Interventional Radiology. 2023 Jun 1
• 26 citations
  BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
  In-Young Jung, Vivek Narayan, Sierra McDonald, Andrew J Rech, Robert Bartoszek, Gwanui Hong, Megan M Davis, Jun Xu, Alina C Boesteanu, Julie S Barber-Rotenberg, Gabrie...> ;Science Translational Medicine. 2022 Nov 9
• 1 citations
  When Clot Is Tumor: A Roadmap to Anticoagulation in Renal Cell Carcinoma With Tumor Thrombus.
  Naomi Balzer-Haas, Miles Hsu> ;JACC. Cardiooncology. 2022 Nov 1
• 29 citations
  Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).
  Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe Ornstein, M...> ;Journal of Clinical Oncology. 2022 Sep 1
• 94 citations
  Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, rand...
  Thomas Powles, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Stefan N Symeonides, Jaroslav Hajek, Howard Gurney, Yen-Hwa Chang, Jae Lyun Lee, Naveed ...> ;The Lancet. Oncology. 2022 Sep 1
• 7 citations
  ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
  Mark N Stein, Lawrence Fong, Ronald Tutrone, Anthony Mega, Elaine T Lam, Megan Parsi, Surya Vangala, Andres A Gutierrez, Naomi B Haas> ;The Oncologist. 2022 Jun 8
• 20 citations
  Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial.
  Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, Richard J Lee, Melinda L Telli, Alice C Fan, Angela DeMichele, Naomi B Haas, Manish R Patel, James J Harding, M...> ;Clinical Cancer Research. 2022 Apr 14
• 149 citations
  PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
  Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, Simon F Lacey, Andrew J Rech, Megan M Davis, Wei-Ting Hwang, Priti Lal, Erica L Carpenter, Shannon L Maude, Gab...> ;Nature Medicine. 2022 Apr 1
• 52 citations
  From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
  Choueiri, T., Albiges, L., Atkins, M., Bakouny, Z., Bratslavsky, G., Braun, D., Haas, N., Haanen, J., Hakimi, A., Jewett, M., Jonasch, E., Kaelin, W., Kapur, P., Labak...> ;Clinical Cancer Research. 2022 Mar 1
• Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
  Amita Patnaik, Shirish Gadgeel, Kyriakos P Papadopoulos, Drew W Rasco, Naomi B Haas, Hirak Der-Torossian, Demiana Faltaos, Diane Potvin, Vanessa Tassell, Manal Tawashi...> ;Targeted Oncology. 2022 Mar 1
• 4 citations
  Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
  Amita Patnaik, Shirish Gadgeel, Kyriakos P Papadopoulos, Drew W Rasco, Naomi B Haas, Hirak Der-Torossian, Demiana Faltaos, Diane Potvin, Vanessa Tassell, Manal Tawashi...> ;Targeted Oncology. 2022 Mar 1
• 231 citations
  Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I Carlo, Toni K Choueiri, Brian A Costello, Ithaar H Derweesh, Arpi...> ;Journal of the National Comprehensive Cancer Network. 2022 Jan 1
• 18 citations
  Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer.
  Tanya B. Dorff, Vivek Narayan, Stephen J. Forman, Peter Zang, Joseph A. Fraietta, Carl H. June, Naomi B. Haas, Saul J. Priceman> ;Clinical Cancer Research. 2021 Oct 21
• 291 citations
  Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
  Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Yen-Hwa Chang, Jaroslav Hajek, Stefan N Symeonides, Jae Lyun Lee, Naveed Sarwar, Antoi...> ;The New England Journal of Medicine. 2021 Aug 19
• Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.
  Caitlin C. Murphy, Hannah Fullington, David E. Gerber, Isaac Alex Bowman, Maneka Puligandla, Janice P. Dutcher, Robert S. DiPaola, Naomi B. Haas> ;Cancer Medicine. 2021 Aug 18
• 32 citations
  Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
  Andres F. Correa, Opeyemi Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Adebowale J. Adeniran, Edward M. Messing, Judith Manola, Christopher G. Wood, Chri...> ;European Urology. 2021 Jul 1
• 2 citations
  Use of Bone Resorption Inhibitors in Metastatic Castration-Resistant Prostate Cancer-20 Years Later, and the Answer Is Still Yes.
  Samuel U Takvorian, Naomi B. Haas> ;JAMA Network Open. 2021 Jul 1
• 1 citations
  Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
  Naomi B. Haas, Michael J. LaRiviere, Thomas H. Buckingham, Yauheniya Cherkas, Karl Calara-Nielsen, Brad Foulk, Jaymala Patel, Steven Gross, Denis Smirnov, David J. Vau...> ;Prostate Cancer and Prostatic Diseases. 2021 Jun 1
• 8 citations
  Adoptive Cellular Therapy for Solid Tumors.
  Adham S. Bear, Joseph A. Fraietta, Vivek Narayan, Mark H. O'Hara, Naomi B. Haas> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2021 May 19
• 6 citations
  Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).
  Wenxin Xu, Maneka Puligandla, Brian Halbert, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Venkata S. Sabbisetti, Rupal S. Bhatt> ;Clinical Cancer Research. 2021 Apr 8
• 33 citations
  Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3...
  Robert J. Motzer, Paul Russo, Naomi B. Haas, Christian Doehn, Frede Donskov, Marine Gross-Goupil, Sergei Varlamov, Evgeny Kopyltsov, Jae-Lyun Lee, Ho Yeong Lim, Bohusl...> ;European Urology. 2021 Mar 1
• 122 citations
  A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
  Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson, Naomi S. Balzer-Haas, Daniel J. George, Daniel Y.C. Heng, Brian Shuch, Mark N. Stein, Maria S. Tretiakova, Peter ...> ;Lancet. 2021 Feb 20
• 162 citations
  Kidney cancer, version 1.2021: Featured updates to the nccn guidelines
  Robert J. Motzer, Eric Jonasch, Shawna L. Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Itha...> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
• 11 citations
  Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.
  Sundeep Agrawal, Naomi B. Haas, Mohammadhadi Bagheri, Brian R. Lane, Jonathan A. Coleman, Hans J. Hammers, Gennady Bratslavsky, Cynthia Chauhan, Lauren Kim, Venkatesh ...> ;JAMA Oncology. 2020 Jan 1
• Join now to see all